JAGX vs T · rev $1.2M vs P/E 7.4, rev $63.06B
Jaguar Animal Health Inc (JAGX) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Jaguar Animal Health Inc (JAGX) is a biotechnology company listed on NASDAQ.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported JAGX revenue for 2026-06-30 was $1.2M. Net income was -$12.8M. Revenue was down 94.0% from 2026-03-31 to 2026-06-30. JAGX currently screens at market cap $1.7M.
Latest reported T revenue for 2026-06-30 was $63.06B. Net income was $8.46B. T currently screens at market cap $155.92B and trailing P/E 7.4.
JAGX currently screens at market cap $1.7M. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the JAGX and T stock pages for the full models.
Not investment advice.